Mind Connections Specialist Health Services is Now Offering Spravato (Nasal Ketamine)

We are excited to introduce Spravato (esketamine) nasal spray at Mind Connections Specialist Health Services—a groundbreaking treatment for treatment-resistant depression (TRD). If you have struggled with depression and haven’t responded to standard therapies, Spravato may offer new hope.

Starting Spravato treatment at Mind Connections Specialist Health Services can be a new and hopeful step for patients with treatment-resistant depression (TRD). Spravato treatment is the latest addition to our modern treatment armamentarium. Many of you know that we have already established the best repetitive Transcranial Magnetic Stimulation (rTMS), another groundbreaking treatment, which is known as non-medication therapy.

We are proud that by providing effective treatment, we save so many hospital admissions as we work in the early intervention and relapse prevention space. We create a win-win situation, saving tax payer’s money, empowering individuals for a happy and productive life and creating happy families.

>> Best rTMS Treatment for Depression in Australia

What is Spravato?

Spravato is a TGA-approved nasal spray derived from Ketamine, designed to work differently from standard antidepressants by targeting glutamate pathways in the brain. It has been shown to provide rapid symptom relief, often within weeks, when used alongside antidepressant therapy.

Who is Eligible for Spravato?

To be considered for Spravato treatment, you must:

Have a confirmed diagnosis of treatment-resistant depression, meaning you have not responded to at least two different antidepressants in adequate doses.
Undergo a thorough psychiatric assessment with one of our psychiatrists to evaluate suitability and ensure the treatment aligns with your mental and physical health history.
Be free from certain medical conditions that may pose a risk, such as uncontrolled hypertension or a history of substance misuse.

What to Expect During Treatment

Thorough Psychiatric Assessment: Before starting Spravato, a comprehensive psychiatric evaluation is necessary to determine if this treatment is appropriate for you. If you are considering Ketamine treatment, book a consultation for a detailed assessment so we can discuss whether this innovative treatment is right for you.
In-Clinic Supervised Administration: Spravato is self-administered under medical supervision, with a mandatory monitoring period of at least two hours to ensure safety.
A personalized treatment plan tailored to your needs. The potential side effects need careful monitoring at the clinic. Some patients may experience dizziness, dissociation, nausea, or sedation, which typically subside within a few hours. Our Spravato treatment program follows a structured approach in a safe, supervised clinical setting.

What to Expect During Spravato (Nasal Ketamine) Treatment

Here’s what you might experience during and after each session:

Before Treatment

You’ll have a consultation with your psychiatrist to determine if Spravato is right for you.
On treatment days, it’s recommended to have someone drive you home, as Spravato can cause temporary side effects.

During Treatment

The nasal spray is self-administered under medical supervision in our clinic.
After administration, you will rest in a comfortable chair while our team monitors you for at least two hours to ensure safety.
You may experience dissociation (feeling detached), dizziness, nausea, or sedation, but these effects usually wear off within a few hours.

After Treatment

Some patients report feeling lighter, more relaxed, or experiencing a mood lift within hours or days.
It may take several sessions to notice a significant improvement, and results vary for each person.
You’ll have regular follow-ups to track progress and adjust your treatment plan as needed.

Cost

Medicare does not cover Spravato at present, and this may change in the future. However, most third-party insurers and the Department of Veterans Affairs (DVA) cover the cost for eligible patients with treatment-resistant depression.

Spravato is a promising option for those who haven’t responded to traditional antidepressants. If you or a loved one is struggling, reach out to us to see if this treatment could be the right fit.